Medtech Atmo preps to surf GLP-1 wave

MELBOURNE: Melbourne’s Atmo Biosciences has slashed its valuation from $70 million to $25 million, despite… read more

HotDoc’s Hurst steps down after fourteen years at the helm

SYDNEY: The chief executive of digital doctors’ booking platform HotDoc has resigned after 14 years,… read more

CSL investors cheered by news of green light for clinical trials

SYDNEY: CSL investors had a welcome reprieve on Wednesday, after the ASX-listed biotech unveiled a… read more

13 new senior healthcare executives sought for key roles

MELBOURNE: Thirteen new disability executive positions remain open. New positions listed today include: Chief Executive… read more